Inovise Medical Announces Agreement with Delphi Medical Systems for Vital Signs Monitors.

PORTLAND, Ore. -- Inovise Medical announced today during the Society of Chest Pain Centers Conference being held in Orlando, FL that it has signed a worldwide licensing agreement with Delphi Medical Systems, a subsidiary of Delphi Corporation. Under the terms of the agreement, Delphi Medical Systems will manufacture and distribute vital signs monitors with AUDICOR(R) software and sensor technology integrated into its user-friendly devices. This agreement marks a major milestone in Inovise Medical's strategy for making AUDICOR(R) a standard of care for diagnosing and monitoring heart failure and other high-risk cardiac conditions.

Nearly 5 million patients in the US live with heart failure, with 550,000 new cases reported each year. Heart failure is the underlying cause for 12 to 15 million office visits and 6.5 million hospital days each year, and represents the most expensive disease for the US health care system. By partnering with Delphi Medical Systems, Inovise Medical's AUDICOR(R) technology will play a significant role in the trend towards managing these patients outside the hospital, in lower cost clinic settings, and even in the patient's home, helping to reduce overall costs and improve the entire continuum of care for millions of heart failure patients.

"We are very excited to have Delphi Medical Systems integrate and market our AUDICOR(R) technology in its monitors," said Patti White, CEO of Inovise Medical. "This partnership represents a natural progression for AUDICOR(R), from the diagnosis of heart failure and other high-risk cardiac diseases, to helping clinicians better monitor and manage these patients. Delphi Medical Systems' technical, manufacturing, distribution, and marketing expertise in the vital signs monitoring market will help contribute to AUDICOR(R)'s success in this market."

"Heart failure is a major and growing problem for the health care system," commented Christophe Sevrain, Managing Director of Delphi Medical Systems. "By adding AUDICOR(R) to our vital signs monitors, we will be able to offer a valuable cardiac monitoring function that enables clinicians to better manage their heart failure patients."

About Inovise Medical, Inc.

Inovise Medical, Inc., of Portland, Oregon is a privately held company founded in 1997 by former members of Hewlett-Packard's Diagnostic Cardiology Division's management and technical team. Inovise Medical's AUDICOR technology combines automated heart sound detection and analysis with advanced electrocardiography, and presents both graphical and textual results in a comprehensive single-page format. AUDICOR(R) uses correlated audioelectric cardiography to help clinicians rapidly and accurately assess patients presenting with symptoms of acute heart failure, acute coronary syndrome, and other high-risk cardiac conditions, resulting in earlier administration of definitive therapy. Additional information on Inovise Medical, Inc. and AUDICOR technology may be found at http://www.audicor.com

About Delphi Medical Systems

Delphi Medical Systems is a world-class provider of technology, products, and product development and manufacturing for respiratory care, IV infusion, vital signs monitoring, dialysis equipment, in-vitro diagnostics and surgical /hospital equipment. Its capabilities stem from Delphi's vast technology base, product development expertise and manufacturing excellence. For more information on Delphi Medical Systems, please visit http://www.delphimedical.com.